Back to Articles
Guides12 min readAugust 11, 2026
Tru Niagen Review: The NAD+ Supplement With Actual Regulatory Paperwork
Tru Niagen sells Niagen, a patented nicotinamide riboside that is the only NR product notified to the FDA as GRAS and a New Dietary Ingredient. That regulatory paperwork is the real differentiator. Verified August 11, 2026.
By Med Consumer Watch Team
Tru Niagen sells NAD+ precursor supplements built on Niagen®, its patented form of nicotinamide riboside (NR). Prices run roughly $39.20 to $116.00 depending on strength and pack size, with subscribe and save at 20% plus free shipping, and the company states it now accepts HSA/FSA.
It is for people interested in the NAD+ category who want the ingredient with the most regulatory and research backing behind it.
The genuine differentiator is unglamorous: Niagen is, per the company, the only NR product notified to the FDA as GRAS and as a New Dietary Ingredient. That is a checkable regulatory position rather than a marketing claim, and it is explained below.
This review contains affiliate links and we may earn a commission if you buy through them. The assessment is our own. Verified against Tru Niagen's own pages on August 11, 2026. Not medical advice.
GRAS and NDI - why the paperwork is the story
Most supplement differentiation is packaging. This one is regulatory, and it is worth understanding because it is unusual.
The company states: "Niagen is the only NR product that has been notified to the FDA as GRAS and a New Dietary Ingredient."
What those two things mean:
GRAS — Generally Recognized As Safe. A determination that qualified experts consider an ingredient safe for its intended use. A GRAS notification submits that determination to the FDA, which reviews it and may respond with a "no questions" letter. It is a safety pathway, not an efficacy approval.
NDI — New Dietary Ingredient notification. Under US law, ingredients not marketed before 1994 generally require a notification to the FDA including safety evidence, submitted 75 days before marketing. A great many supplement ingredients on the market have never been through this process.
Why it matters for a consumer. Neither is an FDA approval and neither says the product works. What they say is that the ingredient's safety has been formally submitted for federal review rather than simply asserted — which, in a category where most ingredients arrive with neither, is a meaningful distinction.
Set against the NAD+ category generally. We reviewed Happy Aging earlier, whose claim was "500+ clinical studies on our key ingredients" — accurate, and a statement about research volume rather than regulatory standing. Tru Niagen's claim is a different kind of thing, and a more checkable one.
It is still a supplement. Not FDA-approved for efficacy, and not permitted to claim it treats disease.
When comparing supplement ingredients, ask whether the ingredient has an NDI notification. Many do not, and the difference between "we submitted safety data to the FDA" and "we put it in a capsule" is real even though neither is an approval.
What the evidence does and does not show
NAD+ is a genuinely important coenzyme involved in cellular energy metabolism and DNA repair, and its levels do decline with age. That much is settled biology, and it is why the category exists.
What NR supplementation has reasonably good evidence for: raising NAD+ levels in blood. Multiple human trials support that NR increases circulating NAD+, which is why the company's "up to 150%" style claims about NAD+ levels are the most defensible thing it says.
What remains unestablished: whether raising NAD+ produces meaningful improvements in healthspan, longevity, or the specific outcomes the category is marketed around. Raising a biomarker is not the same as improving health, and this is the gap between what the research shows and what the marketing implies across the entire NAD+ industry.
A point in Tru Niagen's favour worth noting. The company publishes a science blog that engages with challenging research rather than ignoring it — including a piece framed around a study questioning whether blood is the right way to measure NAD+ decline, presented as "an honest look." A supplement company publicly grappling with a study that complicates its own category is behaving better than the norm.
Buy accordingly: the ingredient reliably does the biochemical thing it claims. Whether that biochemical thing makes you healthier is the open question, and honest sellers in this space acknowledge it.
Pricing, HSA/FSA and the product range
Verified on August 11, 2026. Prices sat at $39.20, $49.00, $92.80 and $116.00 across strengths and pack sizes, with subscribe and save at 20% off all orders plus free shipping.
HSA/FSA acceptance is worth a note, because we have examined two very different versions of this claim recently. Supplements are generally not qualified medical expenses without a Letter of Medical Necessity — unlike sunscreen at Ulta, which qualifies outright, and more like the bedding claim at Rest. Check what documentation your plan administrator requires before assuming pre-tax funds apply; the company's "learn more" link is the place to start.
The range has expanded beyond capsules into NAD+ skincare ("Niagen NanoCloud"), a whole-body benefits bundle, and — notably — a pharmaceutical-grade at-home injection kit marketed as prescription Niagen under a Niagen Plus line.
That last one deserves separate scrutiny. A prescription injectable is a different product class from a capsule, with different risks, different oversight and a different cost base. If you are considering it, that is a conversation with a clinician rather than an e-commerce decision, and the questions to ask are what it is prescribed for, by whom, and what monitoring accompanies it.
On the 20% subscription: reasonable, and this is a genuinely daily-use product category, so a subscription is more defensible here than for episodic purchases. Confirm the cancellation process before enrolling.
- Item | Detail
- Price range | $39.20-$116.00 by strength and pack
- Subscribe & Save | 20% off all orders plus free shipping
- HSA/FSA | Accepted - confirm documentation your plan requires
- Core ingredient | Niagen patented nicotinamide riboside (NR)
- Regulatory | GRAS and New Dietary Ingredient notifications (company-stated)
- Range | Capsules, NAD+ skincare, prescription injectable line
Safety and who should check first
NR has a better-characterised safety profile than most supplement ingredients, which is largely what the GRAS and NDI notifications reflect. It is generally well tolerated in human trials.
Check with a clinician before starting if you:
Are pregnant, breastfeeding or trying to conceive — safety has not been established
Take prescription medication — supplement-drug interactions are under-studied generally
Have a history of cancer or are in treatment. This warrants emphasis: NAD+ metabolism is relevant to cell proliferation, and the effect of boosting it in the context of cancer is not settled. Raise it with an oncologist rather than assuming neutrality
Have kidney or liver impairment
On the injectable line specifically: any injectable carries risks a capsule does not — infection, injection-site reactions, dosing errors. A prescription product requires a prescriber, and that relationship should be a real clinical one rather than a formality.
Regulatory framing. These are dietary supplements. The FDA does not approve supplements for efficacy, and no supplement may lawfully claim to treat or prevent disease. The GRAS and NDI notifications concern safety review, not effectiveness.
How it compares
The NAD+ precursor market splits mainly between NR and NMN, and there is a regulatory wrinkle worth knowing.
NR is the ingredient Tru Niagen sells, with the GRAS and NDI notifications described above.
NMN has been the subject of a contested regulatory position in the US in recent years regarding its status as a dietary supplement ingredient. That is a live issue rather than a settled one, and it is a reason to check the current position on any NMN product before buying.
Against Happy Aging, reviewed earlier: that brand's strengths are per-batch third-party testing and a named medical advisor; Tru Niagen's is regulatory standing and a deeper research base for its specific ingredient. Both are premium priced.
Against doing something else with the money: the honest comparison remains that sleep, resistance training, protein adequacy and blood pressure control have far stronger evidence for healthy ageing and cost little. A supplement is a reasonable addition; it is a poor substitute.
- Ingredient | Regulatory standing | Evidence for raising NAD+
- Niagen NR (Tru Niagen) | GRAS and NDI notifications | Good - multiple human trials
- NMN | Contested US status - check current position | Research exists
- Generic NR | Varies | Varies by product
- Diet, sleep, training | n/a | Strongest evidence for healthy ageing
Frequently asked questions
Does Tru Niagen work?
NR reliably raises circulating NAD+ in human trials. Whether raising NAD+ improves healthspan or longevity is not established. Buy on the first, not the second.
What is Niagen?
Tru Niagen's patented form of nicotinamide riboside, an NAD+ precursor.
What do GRAS and NDI mean?
GRAS is a safety determination submitted to the FDA; NDI is a required safety notification for ingredients not marketed before 1994. Both concern safety review, not efficacy, and many supplement ingredients have neither.
Is it FDA approved?
No. The FDA does not approve supplements for efficacy.
NR or NMN?
NR has the clearer US regulatory standing. NMN's status as a supplement ingredient has been contested — check the current position before buying an NMN product.
Is it HSA/FSA eligible?
The company states it accepts HSA/FSA. Supplements typically require a Letter of Medical Necessity — confirm what your plan administrator needs.
What about the injectable?
A prescription pharmaceutical-grade line exists. That is a clinical decision requiring a prescriber, not an e-commerce one.
Is it safe?
Generally well tolerated. Check with a clinician if pregnant, on medication, or with a cancer history, given NAD+'s relevance to cell proliferation.
The Bottom Line
Our rating: 7.5 / 10. The most defensible product in a category where defensibility is scarce — and still a supplement, with everything that implies.
Tru Niagen's differentiator is regulatory rather than promotional, which is unusual enough to lead on. Niagen being, per the company, the only NR product notified to the FDA as both GRAS and a New Dietary Ingredient is a checkable position, and in a market where a large share of ingredients have neither, it means the safety case was formally submitted rather than assumed. The published science blog engaging honestly with a study that complicates its own category is the kind of behaviour that should be rewarded in a sector that usually ignores inconvenient research.
The reservation is the same one that applies to the whole NAD+ industry, and it is not a small one. NR reliably raises circulating NAD+ — that is well supported. Whether raising NAD+ improves healthspan or longevity is unestablished. The category is marketed on the second while the evidence supports the first, and no amount of regulatory paperwork closes that gap.
Two practical notes. The HSA/FSA acceptance likely requires documentation, as supplements generally do — check with your administrator rather than assuming. And the prescription injectable line is a clinical decision, not a shopping one.
Buy it if you want the NAD+ precursor with the strongest regulatory footing and you are clear you are buying a biomarker effect rather than a proven outcome. Spend the money elsewhere if it would compete with sleep, training and protein — which have far stronger evidence and cost far less.
Check Tru Niagen's current range and pricing
Informational only, not medical advice. Dietary supplements are not FDA-approved for efficacy and are not intended to diagnose, treat, cure or prevent any disease. GRAS and NDI notifications concern safety review, not effectiveness. Consult a clinician before starting, particularly if pregnant, breastfeeding, taking medication, or with a history of cancer. Prices verified August 11, 2026 and subject to change.
Sources & References
Medical Disclaimer
This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.
Enter to Win a $1,788 CoreAge Rx Gift Card
Enter for a chance to use it toward eligible CoreAge Rx products and services.
The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.